To the contrary, the gene MYC was consistently and gradually downregulated in both endometrial (Figure 1F) and head and neck cancer patients (Figure 2F) from the first time point (1 day post-first fraction) to the last one (5 weeks) where the downregulation became significant for the endometrial patients. Here, MYC is linked to head and neck cancer.